• 1
    The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772.
  • 2
    Kondo Y, Kondo F, Wada K, Okabayashi A. Pathologic features of small hepatocellular carcinoma. Acta Pathol Jpn 1986; 36: 11491161.
  • 3
    Wakasa K, Sakurai M, Okamura J, Kuroda C. Pathological study of small hepatocellular carcinoma: frequency of their invasion. Virchows Arch 1985; 407: 259270.
  • 4
    Stetier-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541573.
  • 5
    Cottam DW, Rees RC. Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int J Oncol 1993; 2: 861872.
  • 6
    Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Grit Rev Oral Biol Med 1993; 4: 197250.
  • 7
    Bernhard EJ, Muschel RJ, Hughes EN. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 1990; 50: 38723877.
  • 8
    Nakajima M, Welch DR, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987; 47: 48694876.
  • 9
    Nakatsukasa H. Type IV collagen-degrading enzyme activity in hepatocellular carcinoma. Acta Med Okayama 1986; 40: 8391.
  • 10
    Hashimoto N, Kobayashi M, Tsuji T. Serum type collagen-degrading enzyme in hepatocellular carcinoma with metastasis. Acta Med Okayama 1988; 42: 16.
  • 11
    Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994; 231: 7988.
  • 12
    Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993; 53: 140146.
  • 13
    Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M, Borregaard N. Human neutrophil gelatinase: a marker for circulating blood neutrophils purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol 1992; 49: 180191.
  • 14
    Bailar JC III, Mosteller F. Guidlines for statistical reporting in articles for medical journals, amplifications and explanations. Ann Intern Med 1988; 108: 266273.
  • 15
    Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 12851293.
  • 16
    Fujiyama S, Izuno K, Yamasaki K, Sato T, Takeda 1C Determination of optimum cutoff levels of plasma des-r-carboxy prothrombin and serum alpha-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves. Tumour Biol 1992; 13: 316323.
  • 17
    French DL, Ramos-Desimone N, Rozinski K, Nuovo GJ. Matrix metalloproteinase-9 in tumor cell invasion. Ann N Y Acad Sci 1994; 732: 324334.
  • 18
    Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells, purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 2171221719.
  • 19
    Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 1993; 104: 991999
  • 20
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H et al. Localization of matrix metalloproteinase 9(92-kilodalton gelatinase/type IV collagenase-gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995; 72: 311322.
  • 21
    Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJP, Arther JP. Kupffer cell-derived 95-kd type IV collagenase/ gelatinase B: characterization and expression in cultured cells. Hepatology 1995; 2: 304315.
  • 22
    Winwood PJ, Green I, Strain A, Arther MJP. Release of 95 KD type IV collagenase/gelatinase by human Kupffer cells and its expression in diseased human liver. In: KnookDL, WisseE, eds. Cells of the hepatic sinusoid. Vol 4. Leiden: Kupffer Cell Foundation, 1993: 301303.
  • 23
    Lindsay CK, Thorgeirsson UP. Localization of messenger RNA for tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinases in monkey hepatocellular carcinomas. Clin Exp Metastasis 1995; 13: 381388.
  • 24
    Asida K, Nakatsukasa H, Azuma T, Ookuchi S, Hino N, Nouso K, Urabe T, et al. Cellular distribution of 92kDa type IV collagenase (MMP9) transcripts in human hepatocellular carcinoma [Abstract]. Acta Hepatol Jpn 1995; 36: 349.
  • 25
    Jeziorska M, Haboubi NY, Schfield PF, Ogata Y, Nagase H, Woolley DE. Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colorectal Dis 1994; 9: 141148.
  • 26
    Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano 1C 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65: 5762.